Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms

<p>Abstract</p> <p>Background</p> <p>This study examined associations of abdominal adiposity with lung function, asthma symptoms and current doctor-diagnosed asthma and mediation by insulin resistance (IR) and sleep disordered breathing (SDB).</p> <p>Methods...

Full description

Bibliographic Details
Main Authors: Haren Matthew T, Misan Gary, Paterson Tracey-Jayne, Ruffin Richard E, Grant Janet F, Buckley Jonathan D, Howe Peter RC, Newbury Jonathan, Taylor Anne W, McDermott Robyn A
Format: Article
Language:English
Published: BMC 2012-06-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:http://www.biomedcentral.com/1471-2466/12/31
id doaj-eb18d6da87bc4ea1acf41a0d1fe43fa2
record_format Article
spelling doaj-eb18d6da87bc4ea1acf41a0d1fe43fa22020-11-24T23:39:29ZengBMCBMC Pulmonary Medicine1471-24662012-06-011213110.1186/1471-2466-12-31Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanismsHaren Matthew TMisan GaryPaterson Tracey-JayneRuffin Richard EGrant Janet FBuckley Jonathan DHowe Peter RCNewbury JonathanTaylor Anne WMcDermott Robyn A<p>Abstract</p> <p>Background</p> <p>This study examined associations of abdominal adiposity with lung function, asthma symptoms and current doctor-diagnosed asthma and mediation by insulin resistance (IR) and sleep disordered breathing (SDB).</p> <p>Methods</p> <p>A random sample of 2500 households was drawn from the community of Whyalla, South Australia (The Whyalla Intergenerational Study of Health, WISH February 2008 - July 2009). Seven-hundred twenty-two randomly selected adults (≥18 years) completed clinical protocols (32.2% response rate). Lung function was measured by spirometry. Post-bronchodilator FEV<sub>1</sub>/FVC was used to measure airway obstruction and reversibility of FEV<sub>1</sub> was calculated. Current asthma was defined by self-reported doctor-diagnosis and evidence of currently active asthma. Symptom scores for asthma (CASS) and SDB were calculated. Intra-abdominal fat (IAF) was estimated using dual-energy x-ray absorptiometry (DXA). IR was calculated from fasting glucose and insulin concentrations.</p> <p>Results</p> <p>The prevalence of current doctor-diagnosed asthma was 19.9% (95% CI 16.7 – 23.5%). The ratio of observed to expected cases given the age and sex distribution of the population was 2.4 (95%CI 2.1, 2.9). IAF was not associated with current doctor-diagnosed asthma, FEV<sub>1</sub>/FVC or FEV<sub>1</sub> reversibility in men or women but was positively associated with CASS independent of IR and SDB in women. A 1% increase in IAF was associated with decreases of 12 mL and 20 mL in FEV<sub>1</sub> and FVC respectively in men, and 4 mL and 7 mL respectively in women. SDB mediated 12% and 26% of these associations respectively in men but had minimal effects in women.</p> <p>Conclusions</p> <p>In this population with an excess of doctor-diagnosed asthma, IAF was not a major factor in airway obstruction or doctor-diagnosed asthma, although women with higher IAF perceived more severe asthma symptoms which did not correlate with lower FEV<sub>1</sub>. Higher IAF was significantly associated with lower FEV<sub>1</sub> and FVC and in men SDB mechanisms may contribute up to one quarter of this association.</p> http://www.biomedcentral.com/1471-2466/12/31Airway obstructionForced Expiratory VolumeForced Vital CapacityAsthmaAbdominal adipositySleep disordered breathing
collection DOAJ
language English
format Article
sources DOAJ
author Haren Matthew T
Misan Gary
Paterson Tracey-Jayne
Ruffin Richard E
Grant Janet F
Buckley Jonathan D
Howe Peter RC
Newbury Jonathan
Taylor Anne W
McDermott Robyn A
spellingShingle Haren Matthew T
Misan Gary
Paterson Tracey-Jayne
Ruffin Richard E
Grant Janet F
Buckley Jonathan D
Howe Peter RC
Newbury Jonathan
Taylor Anne W
McDermott Robyn A
Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
BMC Pulmonary Medicine
Airway obstruction
Forced Expiratory Volume
Forced Vital Capacity
Asthma
Abdominal adiposity
Sleep disordered breathing
author_facet Haren Matthew T
Misan Gary
Paterson Tracey-Jayne
Ruffin Richard E
Grant Janet F
Buckley Jonathan D
Howe Peter RC
Newbury Jonathan
Taylor Anne W
McDermott Robyn A
author_sort Haren Matthew T
title Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
title_short Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
title_full Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
title_fullStr Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
title_full_unstemmed Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
title_sort abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
publisher BMC
series BMC Pulmonary Medicine
issn 1471-2466
publishDate 2012-06-01
description <p>Abstract</p> <p>Background</p> <p>This study examined associations of abdominal adiposity with lung function, asthma symptoms and current doctor-diagnosed asthma and mediation by insulin resistance (IR) and sleep disordered breathing (SDB).</p> <p>Methods</p> <p>A random sample of 2500 households was drawn from the community of Whyalla, South Australia (The Whyalla Intergenerational Study of Health, WISH February 2008 - July 2009). Seven-hundred twenty-two randomly selected adults (≥18 years) completed clinical protocols (32.2% response rate). Lung function was measured by spirometry. Post-bronchodilator FEV<sub>1</sub>/FVC was used to measure airway obstruction and reversibility of FEV<sub>1</sub> was calculated. Current asthma was defined by self-reported doctor-diagnosis and evidence of currently active asthma. Symptom scores for asthma (CASS) and SDB were calculated. Intra-abdominal fat (IAF) was estimated using dual-energy x-ray absorptiometry (DXA). IR was calculated from fasting glucose and insulin concentrations.</p> <p>Results</p> <p>The prevalence of current doctor-diagnosed asthma was 19.9% (95% CI 16.7 – 23.5%). The ratio of observed to expected cases given the age and sex distribution of the population was 2.4 (95%CI 2.1, 2.9). IAF was not associated with current doctor-diagnosed asthma, FEV<sub>1</sub>/FVC or FEV<sub>1</sub> reversibility in men or women but was positively associated with CASS independent of IR and SDB in women. A 1% increase in IAF was associated with decreases of 12 mL and 20 mL in FEV<sub>1</sub> and FVC respectively in men, and 4 mL and 7 mL respectively in women. SDB mediated 12% and 26% of these associations respectively in men but had minimal effects in women.</p> <p>Conclusions</p> <p>In this population with an excess of doctor-diagnosed asthma, IAF was not a major factor in airway obstruction or doctor-diagnosed asthma, although women with higher IAF perceived more severe asthma symptoms which did not correlate with lower FEV<sub>1</sub>. Higher IAF was significantly associated with lower FEV<sub>1</sub> and FVC and in men SDB mechanisms may contribute up to one quarter of this association.</p>
topic Airway obstruction
Forced Expiratory Volume
Forced Vital Capacity
Asthma
Abdominal adiposity
Sleep disordered breathing
url http://www.biomedcentral.com/1471-2466/12/31
work_keys_str_mv AT harenmatthewt abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT misangary abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT patersontraceyjayne abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT ruffinricharde abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT grantjanetf abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT buckleyjonathand abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT howepeterrc abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT newburyjonathan abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT taylorannew abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT mcdermottrobyna abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
_version_ 1725513230829223936